Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study
- PMID: 28082669
- PMCID: PMC5262530
- DOI: 10.1161/STROKEAHA.116.015071
Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study
Abstract
Background and purpose: To prevent strokes that may occur as the first manifestation of atrial fibrillation (AF), screening programs have been proposed to identify patients with undiagnosed AF who may be eligible for treatment with anticoagulation. However, the frequency with which patients with AF present with stroke as the initial manifestation of the arrhythmia is unknown.
Methods: We estimated the frequency with which AF may present as a stroke in 1809 community-based Framingham Heart Study participants with first-detected AF and without previous strokes, by tabulating the frequencies of strokes occurring on the same day, within 30 days before, 90 days before, and 365 days before first-detected AF. Using previously reported AF incidence rates, we estimated the incidence of strokes that may represent the initial manifestation of AF.
Results: We observed 87 strokes that occurred ≤1 year before AF detection, corresponding to 1.7% on the same day, 3.4% within 30 days before, 3.7% within 90 days before, and 4.8% ≤1 year before AF detection. We estimated that strokes may present as the initial manifestation of AF at a rate of 2 to 5 per 10 000 person-years, in both men and women.
Conclusions: We observed that stroke is an uncommon but measureable presenting feature of AF. Our data imply that emphasizing cost-effectiveness of population-wide AF-screening efforts will be important given the relative infrequency with which stroke represents the initial manifestation of AF.
Keywords: atrial fibrillation; atrial flutter; incidence; mass screening; stroke.
© 2017 American Heart Association, Inc.
Figures
Comment in
-
Letter by Sposato et al Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".Stroke. 2017 Jun;48(6):e142. doi: 10.1161/STROKEAHA.117.017066. Epub 2017 Apr 17. Stroke. 2017. PMID: 28416625 No abstract available.
-
Response by Lubitz et al to Letter Regarding Article, "Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study".Stroke. 2017 Jun;48(6):e143. doi: 10.1161/STROKEAHA.117.017108. Epub 2017 Apr 17. Stroke. 2017. PMID: 28416627 Free PMC article. No abstract available.
References
-
- Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study. Circulation. 2015;131:2176–2184. - PubMed
-
- Hobbs FD, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005;9:iii–iv. ix–x, 1–74. - PubMed
-
- Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111:1167–1176. - PubMed
-
- Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO) European heart journal. 2016
-
- Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace. 2015;17:1023–1029. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 NS017950/NS/NINDS NIH HHS/United States
- K24 HL105780/HL/NHLBI NIH HHS/United States
- R01 HL092577/HL/NHLBI NIH HHS/United States
- R01 HL128914/HL/NHLBI NIH HHS/United States
- R01 AG008122/AG/NIA NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- R01 HL102214/HL/NHLBI NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- 2014105/DDCF/Doris Duke Charitable Foundation/United States
- K23 HL114724/HL/NHLBI NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- R01 HL104156/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
